Factors predicting non-sentinel lymph node involvement in sentinel node positive breast carcinoma. 2011

Merih Güray Durak, and Bülent Akansu, and Mehmet Mustafa Akin, and Ali Ibrahim Sevınç, and Mehmet Ali Koçdor, and Serdar Saydam, and Omer Harmancioğlu, and Hülya Ellıdokuz, and Recep Bekış, and Tülay Canda
Department of Pathology, Dokuz Eylül University, Faculty of Medicine, İzmir, Turkey. merih.guray@deu.edu.tr

OBJECTIVE In routine practice, axillary lymph node dissection is performed in early invasive breast cancer patients with positive sentinel node biopsy. However, sentinel node is the only involved axillary node in 40-70% of patients, and determining factors that predict axillary non-sentinel node involvement will therefore prevent unnecessary axillary lymph node dissection and decrease morbidity. METHODS In this study, 119 invasive breast cancer patients with sentinel node metastasis who underwent axillary lymph node dissection between 1998-2009 at our institution were studied. Primary tumor characteristics and features of the metastatic tumors in sentinel nodes, such as microanatomic location, size of metastasis, and the ratio of metastatic tumor area to the total sentinel node area were evaluated. Student's t-test and multivariate logistic regression were used for statistical analysis. RESULTS The mean age of the patients was 50.7 years (28-80). Forty-three patients (36%) had invasive ductal and 25 patients (21%) had invasive lobular carcinoma. Most of the patients had either pT1 (44%) or pT2 (54%) tumors. Fifty-four patients (45%) had no further positive nodes in the axilla. The metastatic deposits in the sentinel node were subcapsular in 16 patients (13%). The percent area of sentinel node occupied by tumor (p < 0.001), number of sentinel nodes (p=0.041), and microanatomic location of metastatic tumor (p=0.002) were significantly associated with non-sentinel node metastasis in univariate analysis. The percent area of sentinel node occupied by tumor (p < 0.001) and number of sentinel nodes (p=0.033) remained significantly associated with non-sentinel node involvement in multivariate analysis. CONCLUSIONS In patients with invasive breast cancer and positive sentinel node, area percent of sentinel node occupied by tumor, and the number of sentinel nodes removed are independently predictive of non-sentinel node involvement.

UI MeSH Term Description Entries
D008197 Lymph Node Excision Surgical excision of one or more lymph nodes. Its most common use is in cancer surgery. (From Dorland, 28th ed, p966) Lymph Node Dissection,Lymphadenectomy,Dissection, Lymph Node,Dissections, Lymph Node,Excision, Lymph Node,Excisions, Lymph Node,Lymph Node Dissections,Lymph Node Excisions,Lymphadenectomies,Node Dissection, Lymph,Node Dissections, Lymph
D008198 Lymph Nodes They are oval or bean shaped bodies (1 - 30 mm in diameter) located along the lymphatic system. Lymph Node,Node, Lymph,Nodes, Lymph
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009361 Neoplasm Invasiveness Ability of neoplasms to infiltrate and actively destroy surrounding tissue. Invasiveness, Neoplasm,Neoplasm Invasion,Invasion, Neoplasm
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Merih Güray Durak, and Bülent Akansu, and Mehmet Mustafa Akin, and Ali Ibrahim Sevınç, and Mehmet Ali Koçdor, and Serdar Saydam, and Omer Harmancioğlu, and Hülya Ellıdokuz, and Recep Bekış, and Tülay Canda
August 2012, Breast (Edinburgh, Scotland),
Merih Güray Durak, and Bülent Akansu, and Mehmet Mustafa Akin, and Ali Ibrahim Sevınç, and Mehmet Ali Koçdor, and Serdar Saydam, and Omer Harmancioğlu, and Hülya Ellıdokuz, and Recep Bekış, and Tülay Canda
January 2015, Tumori,
Merih Güray Durak, and Bülent Akansu, and Mehmet Mustafa Akin, and Ali Ibrahim Sevınç, and Mehmet Ali Koçdor, and Serdar Saydam, and Omer Harmancioğlu, and Hülya Ellıdokuz, and Recep Bekış, and Tülay Canda
August 2014, Breast (Edinburgh, Scotland),
Merih Güray Durak, and Bülent Akansu, and Mehmet Mustafa Akin, and Ali Ibrahim Sevınç, and Mehmet Ali Koçdor, and Serdar Saydam, and Omer Harmancioğlu, and Hülya Ellıdokuz, and Recep Bekış, and Tülay Canda
November 2022, Annals of surgical oncology,
Merih Güray Durak, and Bülent Akansu, and Mehmet Mustafa Akin, and Ali Ibrahim Sevınç, and Mehmet Ali Koçdor, and Serdar Saydam, and Omer Harmancioğlu, and Hülya Ellıdokuz, and Recep Bekış, and Tülay Canda
January 2022, Breast cancer (Dove Medical Press),
Merih Güray Durak, and Bülent Akansu, and Mehmet Mustafa Akin, and Ali Ibrahim Sevınç, and Mehmet Ali Koçdor, and Serdar Saydam, and Omer Harmancioğlu, and Hülya Ellıdokuz, and Recep Bekış, and Tülay Canda
March 2009, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico,
Merih Güray Durak, and Bülent Akansu, and Mehmet Mustafa Akin, and Ali Ibrahim Sevınç, and Mehmet Ali Koçdor, and Serdar Saydam, and Omer Harmancioğlu, and Hülya Ellıdokuz, and Recep Bekış, and Tülay Canda
January 2006, Breast cancer research and treatment,
Merih Güray Durak, and Bülent Akansu, and Mehmet Mustafa Akin, and Ali Ibrahim Sevınç, and Mehmet Ali Koçdor, and Serdar Saydam, and Omer Harmancioğlu, and Hülya Ellıdokuz, and Recep Bekış, and Tülay Canda
February 2022, Cirugia espanola,
Merih Güray Durak, and Bülent Akansu, and Mehmet Mustafa Akin, and Ali Ibrahim Sevınç, and Mehmet Ali Koçdor, and Serdar Saydam, and Omer Harmancioğlu, and Hülya Ellıdokuz, and Recep Bekış, and Tülay Canda
December 2020, Cirugia espanola,
Merih Güray Durak, and Bülent Akansu, and Mehmet Mustafa Akin, and Ali Ibrahim Sevınç, and Mehmet Ali Koçdor, and Serdar Saydam, and Omer Harmancioğlu, and Hülya Ellıdokuz, and Recep Bekış, and Tülay Canda
January 2022, Breast cancer (Dove Medical Press),
Copied contents to your clipboard!